Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

Spotify's "North Star" Outlook Was Music to Investors Ears

Streaming giant Spotify may be starting to find its groove again. Its Investor Day caught the market's attention, with shares spiking after a prolonged decline.

MarketBeat

Casey’s Is Looking Like a Hot Buy as Growth, Buybacks, and Guidance Align

Casey's General Store is a textbook buy-and-hold stock, self-funding growth, driving cash flow, buying back shares, and paying dividends.

MarketBeat

As Shares Fall, Analyst Are Boosting their Broadcom Price Targets

While Broadcom's latest earnings disappointed markets; Wall Street analysts held steadfast, increasing their price targets amid the large drop in shares.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Everpure: AI Storage Uncertainty Overshadows Breakneck Growth

AI storage supply concerns just hit Everpure shares hard despite posting strong beats and raising guidance. However, analysts are supporting Everpure's outlook.

MarketBeat

Chewy’s Growth Engine Is Stronger Than the Market Thinks

Chewy stock isn't a headline-making growth story but a cash flow machine, improving its cash flow as it buys back stock and reduces the count.

MarketBeat

GameStop’s $2 Billion Buyback Sends a Confusing Signal to Investors

GameStop's core business is improving and showing record profits; improvement is overshadowed by eBay confusion and high short interest.

MarketBeat

Amneal Pharmaceuticals Bets on Biosimilars, Patches to Power Next Growth Phase

Amneal Pharmaceuticals (NASDAQ:AMRX) Co-Founder, President and Co-Chief Executive Officer Chirag Patel said the company is entering a stronger growth phase, driven by momentum in its existing generics portfolio, a newly expanded biosimilars platform and specialty product launches. Speaking at a Gol

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Alnylam Pharmaceuticals Unveils 2030 Targets, Betting on AMVUTTRA and Pipeline Readouts

Alnylam Pharmaceuticals (NASDAQ:ALNY) executives outlined the company’s 2030 financial targets, TTR franchise strategy and near-term pipeline priorities during a Goldman Sachs event hosted by analyst Salveen Richter. Jeff Poulton, Alnylam’s chief financial officer, said the company’s “Alnylam 2030”

MarketBeat

Uranium Energy Q3 Earnings Call Highlights

Uranium Energy (NYSEAMERICAN:UEC) said on its latest earnings call that it advanced several parts of its U.S. uranium production platform during the quarter, including the start of production at Burke Hollow in South Texas and continued development at Christensen Ranch in Wyoming. Founder and Chief

MarketBeat

Oil-Dri Corporation Of America Q3 Earnings Call Highlights

Oil-Dri Corporation Of America (NYSE:ODC) reported stronger fiscal third-quarter sales and operating income, while management cautioned that higher costs and an ongoing capital investment cycle are continuing to pressure margins. On the company’s Q3 fiscal 2026 earnings webcast, Chief Financial Off

MarketBeat

Academy Sports and Outdoors Q1 Earnings Call Highlights

Academy Sports and Outdoors (NASDAQ:ASO) reported a return to comparable sales growth in its fiscal first quarter, with management pointing to gains across all major merchandise divisions, strong e-commerce growth and momentum from newer stores. The sporting goods retailer said first-quarter net sa

MarketBeat

The J.M. Smucker Company’s Dividend: Too Sweet to Ignore?

J.M. Smucker Compay is in the midst of a business turnaround that will deliver an attractive total return for income investors over time.

MarketBeat

From Crypto to AI: Insiders Are Trading These 3 Stocks

See the beaten-down and surging stocks that insiders are trading, from one of the biggest names in crypto to an NVIDIA-linked chip company.

MarketBeat

Amgen Eyes 2026 ‘Springboard’ as Growth Drugs Offset Patent Pressure

Amgen (NASDAQ:AMGN) executives said the company’s first-quarter performance supports its view that 2026 can serve as a “springboard year,” with growth products helping offset increased competition for the denosumab franchise and other losses of exclusivity. Speaking at a Goldman Sachs event, Peter

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

United Natural Foods Q3 Earnings Call Highlights

United Natural Foods (NYSE:UNFI) reported stronger third-quarter fiscal 2026 profitability and cash flow despite lower sales, as management said network optimization, productivity initiatives and supply chain investments continued to reshape the business. On the company’s earnings call, CEO Sandy D

MarketBeat

Titan Machinery Q1 Earnings Call Highlights

Titan Machinery (NASDAQ:TITN) reported fiscal first-quarter results that management said were slightly ahead of expectations, helped by earlier-than-anticipated equipment margin improvement, but the company reaffirmed its full-year outlook as demand remains pressured across key customer groups. Pre

MarketBeat

Lands' End Q1 Earnings Call Highlights

Lands' End (NASDAQ:LE) reported lower first-quarter revenue as a distribution center systems rollout delayed shipments, but executives said underlying demand improved and described the recently completed joint venture with WHP Global as a major strategic reset for the apparel retailer. Chief Execut

MarketBeat

SailPoint Q1 Earnings Call Highlights

SailPoint (NASDAQ:SAIL) reported a stronger-than-expected start to fiscal 2027, with management pointing to continued SaaS migration activity, larger customer commitments and growing demand for identity security tied to artificial intelligence agents and other non-human identities. On the company’s

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Molten Ventures H2 Earnings Call Highlights

Molten Ventures (LON:GROW) said portfolio fair value growth accelerated during the year, while management pointed to defense, space, artificial intelligence and European technology sovereignty as major structural themes shaping its investment strategy. Chief Executive Ben Wilkinson told investors t

MarketBeat

EHang Q1 Earnings Call Highlights

EHang (NASDAQ:EH) said it remains focused on moving from aircraft certification to commercial operations after reporting first-quarter 2026 revenue that was roughly flat year over year but sharply lower than the prior quarter due to delivery timing and seasonal factors. Founder, Chairman and Chief

MarketBeat

Has Temu-Owner PDD's Story Changed After Double Miss?

Temu owner PDD keeps sinking. The company is prioritizing long-term competitiveness over short-term results, creating potential for an extended recovery.

MarketBeat

TH International Q1 Earnings Call Highlights

TH International (NASDAQ:THCH), the operator of Tims China, reported weaker first-quarter 2026 sales as management continued to close underperforming stores, reduce discount-driven promotions and shift resources toward franchising and profitability. On the company’s earnings call, CEO Director Yong

MarketBeat

J. M. Smucker Q4 Earnings Call Highlights

J. M. Smucker (NYSE:SJM) executives said the company is entering fiscal 2027 with momentum across key brands, while cautioning that commodity costs, tariffs and consumer behavior remain important variables in its outlook. During the company’s fiscal fourth-quarter earnings question-and-answer sessi

MarketBeat

Annexon Eyes ‘Win Season’ With Q4 Vision Trial Data, GBS Filings Ahead

Annexon (NASDAQ:ANNX) executives used a Goldman Sachs Healthcare Conference session to outline the company’s upcoming clinical and regulatory catalysts, led by pivotal Phase III data expected in the fourth quarter for vonaprument in geographic atrophy, a form of advanced dry age-related macular dege

MarketBeat

Cybersecurity Earnings: 1 AI Standout and 2 Stocks Under Pressure

Volatility was the operative word to describe the latest round of cybersecurity earnings. See who skyrocketed, and who got markets knocked down a peg.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.